| Consolidated net income | -3.58M |
| Depreciation and amortization | 6.38M |
| Stock compensation expense | |
| Deferred income taxes | |
| Increase (decrease) in long-term deferred revenue | -76K |
| Excess tax benefit of share-based compensation | |
| Credit (gain) loss on available for sale securities | |
| Loss (gain) on disposal of equipment | 4K |
| Unrealized gain on trading securities | |
| Unrealized loss on auction rate security rights | |
| Change in current assets and liabilities, net | -3.89M |
| Net cash provided by operating activities | |
| Purchases of investments | |
| Sales and maturities of investments | |
| Additions to property, plant and equipment | -6.37M |
| Proceeds from sale of equipment | 2K |
| Change in restricted cash | |
| (Increase) decrease in other assets | -18K |
| Net cash provided by investing activities | |
| Proceeds from exercise of stock options | |
| Excess tax benefit of share-based compensation | |
| Noncontrolling interest dividends paid | |
| Net cash provided by (used in) financing activities | |
| Effect of foreign exchange rates on cash | 35K |
| Net increase in cash and cash equivalents | -7.91M |
| Cash and cash equivalents at beginning of period | 62.98M |
| Cash and cash equivalents at end of period | 55.07M |